FY2022 EPS Estimates for Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) Decreased by Analyst

Retrieved on: 2022-11-28 06:19:52

Tags for this article:

Click the tags to see associated articles and topics

FY2022 EPS Estimates for Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) Decreased by Analyst. View article details on hiswai:

Excerpt

... on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections.

Article found on: reporter.am